Role of fluoxertine hypochloride and clomipramine in ameliorating vascular depression and the side effects

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 20, 2005, Pages 24-25

  Chen, Shu Dan ^a   Tan, Xiao Ying ^a   Lui, Chang Jun ^a   Yang, Guang ^a  

^a HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE;

ADULT; AGED; AGITATION; ARTICLE; CHI SQUARE TEST; CIRCULATION; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REGIMEN; EXCITEMENT; FEMALE; HAMILTON SCALE; HEMOSTASIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; NAUSEA; SIDE EFFECT; STROKE; STUDENT T TEST; SYMPTOM; XEROSTOMIA;

EID: 27644476743     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Alexopoulos GS, Meyers BS, Young RC, et al. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54(10):915-22
2. Rothschild AJ, Bates KS, Boehringer KL, et al. Olanzapine response in psychotic depression. J Clin Psychiatry 1999;60(2):116-8
3. Tollefson GD, Sanger TM, Beasley CM, et al. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol Psychiatry 1998;43(11):803-10
4. Chinese source. 2004,8(21):4348
5. Chinese source. 2003,7(1):60
6. Shelton RC, Tollefson GD, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001;158(1):131-4